Skip to main content
. 2014 Aug 18;6(4):48. doi: 10.1186/alzrt280

Table 3.

Mean (standard deviation) and effect size estimates for domain-specific measures of cognitive function over time in treated and untreated patients with mild–moderate Alzheimer’s disease

Measure Assessment
Mean (standard deviation)
Effect size
Time Treated Untreated (Cohen’s d )
DRS attention
Baseline
34.5 (3.2)
35.1 (2.0)
 
 
1 year
33.6 (3.9)
33.6 (3.9)
0.50
 
2 years
31.7 (5.2)
30.2 (7.8)
0.40
DRS initiation
Baseline
29.6 (6.1)
27.2 (6.2)
 
 
1 year
28.6 (6.5)
25.4 (7.8)
0.51
 
2 years
24.6 (9.2)
19.6 (8.7)
0.50
DRS construction
Baseline
5.0 (1.2)
5.4 (1.4)
 
 
1 year
5.0 (1.3)
4.9 (1.8)
0.52
 
2 years
4.3 (1.7)
4.4 (2.0)
 
DRS conceptualization
Baseline
33.3 (5.8)
34.2 (3.8)
 
 
1 year
34.4 (4.6)
32.0 (6.3)
0.53
 
2 years
31.4 (7.1)
27.2 (10.5)
0.60
DRS memory
Baseline
16.9 (4.0)
15.8 (4.3)
 
 
1 year
15.5 (4.2)
14.1 (4.0)
 
 
2 years
12.3 (5.0)
10.4 (4.1)
 
VR2
Baseline
3.4 (5.9)
4.4 (5.6)
 
 
1 year
3.0 (5.4)
1.6 (3.8)
 
 
2 years
1.7 (5.4)
1.3 (2.6)
 
BDS
Baseline
5.3 (2.2)
5.1 (2.5)
 
 
1 year
4.9 (2.1)
4.5 (2.4)
0.40
 
2 years
4.9 (2.5)
3.9 (2.5)
0.50
REY
Baseline
25.7 (9.0)
25.5 (10.8)
 
 
1 year
25.1 (10.1)
21.4 (13.8)
0.5
 
2 years
22.1 (10.6)
17.2 (24.2)
 
Benton Line Orientation Test
Baseline
20.6 (7.6)
19.8 (9.1)
 
 
1 year
18.8 (9.8)
17.2 (9.7)
 
 
2 years
17.7 (9.5)
16.1 (10.3)
 
WCST
Baseline
41.5 (8.3)
36.9 (7.7)
 
 
1 year
41.3 (8.8)
35.3 (10.3)
 
 
2 years
36.6 (9.3)
32.6 (10.1)
 
Boston Naming Test
Baseline
22.2 (5.4)
20.9 (6.3)
 
 
1 year
20.3 (6.7)
17.5 (7.5)
0.50
 
2 years
18.7 (8.3)
13.3 (8.5)
0.60
Semantic Fluency
Baseline
12.4 (4.4)
10.1 (4.3)
 
 
1 year
10.6 (5.1)
7.9 (4.2)
 
 
2 years
8.9 (4.2)
5.8 (4.0)
 
FAS
Baseline
31.6 (12.7)
24.8 (11.6)
 
 
1 year
30.3 (11.6)
21.3 (13.2)
0.73
  2 years 24.0 (11.8) 17.6 (12.1)  

BDS, Backward Digit Span; DRS, Dementia Rating Scale; FAS Controlled Word Association Test; REY, Rey–Osterreith Complex Figure Test; VR2, delayed visual reproduction; WCST Wisconsin Card Sort Test.